Antibiotic Bootcamps for Developers: Discovery and preclinical development challenges

ESCMID/ASM Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance

4-7 October 2022, Dublin (Ireland)

Collaboratively organized by GARDP, AMR Action Fund, CARB-X, JPIAMR, REPAIR Impact Fund and Wellcome Trust


  • Mark Albrecht
  • Ursula Theuretzbacher


  • Characterising a good target
    Heike Brötz-Oesterhelt, Germany
  • Challenges of in vivo studies to support pre-clinical to clinical translation
    Carina Vingsbo, Denmark
  • Considerations in the safety of anti-infectives: target and chemistry de-risking
    James Sidaway, UK

Jointly organized by: